The study for clinical usefulness of the cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer

The study for clinical usefulness of the cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer - The study for clinical usefulness of the NTx as a marker from lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005553

Enrollment

200

Registered

2011-05-04

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer, breast cancer

Interventions

1:Severrity of symptoms of bone metastasis in bone scintigraphy and comparative study of NTx 2-1:Utility examination of NTX in monitor of therapeutic gain after bone metastasis is diagnosed and bone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: lung cancer,breast cancer no malignancy with benign lesion in lung cancer

Exclusion criteria

Exclusion criteria: 1:Patient who judged that research representative or allotment researcher is improper 2:Bisphosphonate administering patient 3:Metabolic bone disease patient 4:Kidney function deterioration patient

Design outcomes

Primary

Measure	Time frame
1:Severrity of symptoms of bone metastasis in bone scintigraphy and comparative study of NTx 2-1:Utility examination of NTX in monitor of therapeutic gain after bone metastasis is diagnosed and bone metastasis progress level 2-2:Utility of bone metastasis index	—

Countries

Japan

Contacts

Public ContactMotohiro Tamiya

Osaka prefectural Medical Center for Respiratory and Allergic Diseases Thoracic Malignancy

moto19781205@yahoo.co.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026